Czechia· CZ-0209429
ZEPATIER
A elbasvir and grazoprevir product containing elbasvir + grazoprevir, registered in Czechia by Merck Sharp & Dohme B.V., Haarlem. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Elbasvir and grazoprevir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AP54 (elbasvir and grazoprevir), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Elbasvir and grazoprevir · ATC J05AP54
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ELBASVIR + GRAZOPREVIR
- Manufacturer
- Merck Sharp & Dohme B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- J05AP54
- ATC class
- Elbasvir and grazoprevir
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl020942928CZK 172123.74
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elbasvir and grazoprevir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandZepatierMerck Sharp & Dohme B.V.
- United StatesZEPATIERMerck Sharp & Dohme LLC
- United KingdomZepatier 50mg/100mg tabletsOriginalis B.V.
- FinlandZEPATIERMerck Sharp & Dohme B.V.
- FranceZEPATIER 50 mg/100 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandZEPATIER 50 mg/100 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandZepatierMerck Sharp & Dohme B.V.*
- NetherlandsZepatier 50mg/100mg, filmomhulde tabletMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zepatier
- Liechtenstein · Zepatier
- Norway · Zepatier
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/09b1ca2c-749a-4c29-b61c-f729b7d94bab GET /v1/drugs/09b1ca2c-749a-4c29-b61c-f729b7d94bab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "50MG/100MG",
"pack_size": "28",
"substance": "ELBASVIR + GRAZOPREVIR",
"cz_kod_sukl": "0209429",
"product_type": "CH",
"substance_codes": "20391,20401",
"registration_state": "R",
"registration_number": "EU/1/16/1119/001"
}See everything about elbasvir and grazoprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.